ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,893.62
0.39%
US Tech 100
19,974.40
-0.13%
Dow Jones
43,389.60
-0.13%
Brent Oil
72.845
-0.12%
Bitcoin
92,410.96
2.06%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Celyad Oncology SA (CYAD) Quote

Celyad Oncology SA

Celyad Oncology SA (CYAD)

Celyad Oncology SA
0.47
0.00
(0.00%)
Closed November 18 4:00PM
Delayed by 15 minutes
0.47
0.00
( 0.00% )
Pre Market: 7:00PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.47
Bid
0.47
Ask
0.52
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
19.472M
Previous Close
0.47
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
41,429,000
Dividend Yield
-
PE Ratio
-3.19
Earnings Per Share (EPS)
-0.2
Revenue
102k
Net Profit
-8.45M

About Celyad Oncology SA

Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm h... Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in the pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.celyad.com
Headquarters
Mont-saint-guibert, Walloon Brabant, Bel
Founded
-

Ask ADVFN Intelligence (AI)

CYAD Latest News

More News

Celyad Oncology annonce la nomination de Matt Kane au poste de CEO

Regulatory News: Celyad Oncology SA (Euronext & Nasdaq : CYAD) (la « Société » ou « Celyad ») est heureuse d’annoncer la nomination de Matt Kane au poste de Directeur Général (Chief...

September 16 2024
Business Wire

Celyad Oncology Reports First Half Year 2024 Financial Results and Recent Business Highlights

The Company continues to bolster its intellectual property estate and to pursue options to monetize it The Company’s two main research and development platforms have delivered proof-of-concept...

September 13 2024
Business Wire

Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights

Regulatory News: Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), today announces its financial results for the fiscal year 2023 ended December 31, 2023, and provides a...

April 04 2024
Business Wire

Celyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SEC

Regulatory News: Celyad Oncology SA (Euronext: CYAD) (« Celyad Oncology » ou la «Société») annonce que la Société déposera volontairement un Formulaire 15F auprès de la Securities and Exchange...

February 08 2024
Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

January 17 2024
Edgar (US Regulatory)

Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024

Trois piliers principaux pour libérer le potentiel des plateformes technologiques propriétaires et de la propriété intellectuelle : Une plateforme technologique exclusive sans édition de génome...

January 16 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRFXPainReform Ltd
$ 1.45
(171.03%)
34.52M
NCNCnoco noco Inc
$ 0.2375
(144.85%)
85.12M
TRNRInteractive Strength Inc
$ 4.14
(63.64%)
2.37M
SMCXDefiance Daily Target 2X Long SMCI ETF
$ 36.90
(44.59%)
282.96k
CTRNCiti Trends Inc
$ 22.97
(40.70%)
40
CBLLCeriBell Inc
$ 12.11
(-51.56%)
101
XNCRXencor Inc
$ 14.11
(-39.15%)
9
UPBUpstream Bio Inc
$ 14.51
(-38.96%)
104
AXGNAxogen Inc
$ 9.50
(-25.78%)
99
IBCPIndependent Bank Corporation
$ 28.25
(-23.65%)
5
NCNCnoco noco Inc
$ 0.2375
(144.85%)
85.12M
PRFXPainReform Ltd
$ 1.45
(171.03%)
34.52M
TFFPTFF Pharmaceuticals Inc
$ 0.403
(10.71%)
18.37M
HCWBHCW Biologics Inc
$ 1.49
(20.16%)
16.27M
SMCISuper Micro Computer Inc
$ 26.45
(22.79%)
10.27M

Discussion

View Full Feed
JosephS JosephS 5 minutes ago
How cute!

You might be interested in this

I am not

Good luck with 1500 per share! I’m sure the elephant hunt in Canada will go swimmingly for you.
FNMA
ExtremelyBullishZig ExtremelyBullishZig 5 minutes ago
It is their job to increase interest in the stock so they can continue to raise money to operate and pay themselves. They don't need to get a drug to market...just pull in a few suckers.

They have been filing useless parents for 10 years now without approving a single drug. I wonder h
AVXL
rbl100 rbl100 5 minutes ago
PRAY FOR AMERICA -

They are still trying to steal election seats. They will be arrested just like the Judge in Minnesota. I warned people this time was different LOL.

https://www.breitbart.com/crime/2024/11/18/minnesota-election-judge-charged-felonies-letting-unregiste
yp_1 yp_1 5 minutes ago
I am afraid I will be dead by that time...
SEV
DogsOverPeople DogsOverPeople 5 minutes ago
700 shares traded at .0034 the day after financials were reported? I’d say that’s pretty much dead 😂

How much money have you lost here btw?
UATG
art2426 art2426 7 minutes ago
>>>I repeat 2025 and beyond are going to be outstanding for BIEL investors.
BIEL
JosephS JosephS 7 minutes ago
Just turn on 1500 per share already

The SPS and JPS will be wiped! All value to the “voting shares!”

Everyone should know this

Don’t check my math. It’s not that important

Pinky promise
FNMA
Big Hook Big Hook 7 minutes ago
A lot of people are going to lose money here if they don’t sell fast. Might already be too late. This is going south fast.
NSAV
1vman 1vman 8 minutes ago
*****🚽DBMM 🚽has had 1 name change 🟥, 3 ticker symbol changes 🟥and 2 R/S🟥

Wonder when the next R/S and name change will happen ???

SOURCE
https://www.otcmarkets.com/stock/DBMM/security

ENOUGH SAID HUZZAH 
DBMM
tw0122 tw0122 8 minutes ago
.96 +'6% Low floater eventually get to targets 
GNS
SuperLogisticsMan SuperLogisticsMan 8 minutes ago
Parris...you are a broken record. You come to the board to flap your mouth only when the stock is not doing so well. But you never say anything when the stock spikes.
CYBL
JakBqk JakBqk 8 minutes ago
You sore losers wish you could flip like me. You wish you could just throw money around for giggles like me and not care if you lose it. You wish you could afford any stock you wanted to buy. Yall mad as hell and attack anyone who doesn't agree with your sentiment I love it ! 🥰
Gott
PHIL
uksausage uksausage 9 minutes ago
Here is independent DD on the status of Allied Green Ammonia (courtesy of CP on facebook)

https://research.csiro.au/hyresource/allied-green-ammonia/?fbclid=IwY2xjawGpYxVleHRuA2FlbQIxMQABHVVkv_90ftaOteLUML6qT153yYJj452a5Xkcu89Qxw5gDwTSGz2mLLZNRg_aem_A_Y3-MThdB4iSiEOPrHRcw
PLUG
nagoya1 nagoya1 9 minutes ago
I prefer you go help calab dropping soap.
Fnma
FNMA
Rkramden Rkramden 9 minutes ago
Xsens Sirius


https://search.app?link=https%3A%2F%2Fwww.marinetechnologynews.com%2Fnews%2Fmovella-launches-xsens-inertial-642435&utm_campaign=aga&utm_source=agsadl1%2Csh%2Fx%2Fgs%2Fm2%2F4
MVLA
Sodapop42 Sodapop42 10 minutes ago
LMAO markdown phase, you don't even know what your talking about. Just a weirdo cosplaying on a message board
PHIL
WeTheMarket WeTheMarket 10 minutes ago
NV44, these are the responses I got thus far:

LowCountry15
25m
The investor sold their warrants, holding stock.

KryptonianTrader
14m
I find the timing very interesting. Could s more significant filming be following this filing? If positive t
HTOO
Orange Cassidy Orange Cassidy 11 minutes ago
Or maybe just maybe shareholders are getting dumped on!
CGAC
art2426 art2426 12 minutes ago
>>>Now, does my good friend Warren Buffett believe believe in dollar cost averaging?
BIEL
JosephS JosephS 12 minutes ago
I prefer 1500 per share! Let’s goooooooooo!
FNMA
fishnman fishnman 12 minutes ago
Thank you for your kind words. Problem found. I accidently hit or check a box that change my acct. Cann wasnt showing up on my computor. Money gone from Cann... it was weird. Corrected my problem this morning and it said if you had accounts with TD and you hit or check that little frickin dot, th
APLD
SuperLogisticsMan SuperLogisticsMan 12 minutes ago
Where?
CYBL
1vman 1vman 12 minutes ago
*****Wh👀ps !!! Theres NO XPERTS here in 🚽HIRU🚽 and pps confirms that sentiment


https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades


ENOUGH SAID HUZZAH🤪 !!!
HIRU
chklingon chklingon 12 minutes ago
Oh! That is interesting! My problem roaming around town in FSD is the total idiots around me speeding, changing lanes at the last minute with no signal, texting and a miriad of other distractions. If all the FSD driving cars had a safe lane, that would indeed be awesome.
TSLA

Your Recent History

NASDAQ
CYAD
Celyad Oncology
LSE
SOYU
Ubs Etc Soybn U
TG
BO81
Federal Republic of Germ...
BIT
MOL
Moltiply
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved